838 related articles for article (PubMed ID: 17252575)
41. [
Metser U; Kulanthaivelu R; Salawu A; Razak A; Mak V; Li X; Langer DL; MacCrostie P; Singnurkar A
J Nucl Med; 2023 Sep; 64(9):1371-1377. PubMed ID: 37414444
[TBL] [Abstract][Full Text] [Related]
42. Port site recurrence diagnosed by positron emission tomography after laparoscopic surgery for colon cancer.
Kosugi C; Ono M; Saito N; Sugito M; Ito M; Murakami K; Sato K; Kotaka M; Nomura S; Arai M; Kobatake T
Hepatogastroenterology; 2005; 52(65):1440-3. PubMed ID: 16201091
[TBL] [Abstract][Full Text] [Related]
43. Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: a prospective study.
Langenhoff BS; Oyen WJ; Jager GJ; Strijk SP; Wobbes T; Corstens FH; Ruers TJ
J Clin Oncol; 2002 Nov; 20(22):4453-8. PubMed ID: 12431968
[TBL] [Abstract][Full Text] [Related]
44. Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities.
Even-Sapir E
J Nucl Med; 2005 Aug; 46(8):1356-67. PubMed ID: 16085595
[TBL] [Abstract][Full Text] [Related]
45. Comparison of bone and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in the evaluation of bony metastases in lung cancer.
Gayed I; Vu T; Johnson M; Macapinlac H; Podoloff D
Mol Imaging Biol; 2003; 5(1):26-31. PubMed ID: 14499159
[TBL] [Abstract][Full Text] [Related]
46. Value of 18fluoro-deoxyglucose positron emission tomography in the staging of recurrent breast carcinoma.
Bender H; Kirst J; Palmedo H; Schomburg A; Wagner U; Ruhlmann J; Biersack HJ
Anticancer Res; 1997; 17(3B):1687-92. PubMed ID: 9179219
[TBL] [Abstract][Full Text] [Related]
47. Positron emission tomography with fluorodeoxyglucose for suspected head and neck tumor recurrence in the symptomatic patient.
Lonneux M; Lawson G; Ide C; Bausart R; Remacle M; Pauwels S
Laryngoscope; 2000 Sep; 110(9):1493-7. PubMed ID: 10983949
[TBL] [Abstract][Full Text] [Related]
48. Incidental detection of an anterior cruciate ligament injury with FDG PET.
Walsh MA; Morag Y; Brown RK
Clin Nucl Med; 2006 Sep; 31(9):543-6. PubMed ID: 16921279
[No Abstract] [Full Text] [Related]
49. The role of positron emission tomography (PET) in the management of cervical lymph nodes metastases from an unknown primary tumour.
Mevio E; Gorini E; Sbrocca M; Artesi L; Mullace M; Caimi F
Acta Otorhinolaryngol Ital; 2004 Dec; 24(6):342-7. PubMed ID: 15952684
[TBL] [Abstract][Full Text] [Related]
50. Cross-sectional imaging in non-melanoma skin cancer of the head and neck.
Lanka B; Turner M; Orton C; Carrington BM
Clin Radiol; 2005 Aug; 60(8):869-77. PubMed ID: 16039922
[TBL] [Abstract][Full Text] [Related]
51. Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging.
Dromain C; de Baere T; Lumbroso J; Caillet H; Laplanche A; Boige V; Ducreux M; Duvillard P; Elias D; Schlumberger M; Sigal R; Baudin E
J Clin Oncol; 2005 Jan; 23(1):70-8. PubMed ID: 15625361
[TBL] [Abstract][Full Text] [Related]
52. Imaging of oncologic patients: benefit of combined CT and FDG PET in the diagnosis of malignancy.
Eubank WB; Mankoff DA; Schmiedl UP; Winter TC; Fisher ER; Olshen AB; Graham MM; Eary JF
AJR Am J Roentgenol; 1998 Oct; 171(4):1103-10. PubMed ID: 9763005
[TBL] [Abstract][Full Text] [Related]
53. F-18 FDG PET evaluation of bronchial plasmacytoma with CT and MRI correlation.
Iagaru A; Mari C; Segall G
Clin Nucl Med; 2006 May; 31(5):279-80. PubMed ID: 16622337
[No Abstract] [Full Text] [Related]
54. [Computerized tomography and magnetic resonance in the diagnosis of recurrent rectal neoplasms: comparison of reliability and errors of both methods].
Golfieri R; Totaro C; Giampalma E; Lalli A; Sbrozzi F; Soro A; Nogara G; Gavelli G
Radiol Med; 1996 May; 91(5):601-9. PubMed ID: 8693127
[TBL] [Abstract][Full Text] [Related]
55. An audit of fusion CT-PET in the management of colorectal liver metastases.
Khan S; Tan YM; John A; Isaac J; Singhvi S; Guest P; Mirza DF
Eur J Surg Oncol; 2006 Jun; 32(5):564-7. PubMed ID: 16564155
[TBL] [Abstract][Full Text] [Related]
56. Advantages and limitations of FDG PET in the follow-up of breast cancer.
Lind P; Igerc I; Beyer T; Reinprecht P; Hausegger K
Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S125-34. PubMed ID: 15085295
[TBL] [Abstract][Full Text] [Related]
57. [Sarcoma of the pulmonary artery--pre- and postoperative radiologic findings in initial tumor manifestation and recurrence].
Fasse A; Kauczor HU; Mayer E; Kreitner KF; Heussel CP; Thelen M
Rofo; 1999 Jan; 170(1):112-8. PubMed ID: 10071656
[TBL] [Abstract][Full Text] [Related]
58. Update on gastrointestinal imaging.
Koslin DB
Rev Gastroenterol Disord; 2002; 2(1):3-10. PubMed ID: 12122977
[TBL] [Abstract][Full Text] [Related]
59. Contribution of (18)fluoro-deoxyglucose positron emission tomography to the work-up of patients with fever of unknown origin.
Buysschaert I; Vanderschueren S; Blockmans D; Mortelmans L; Knockaert D
Eur J Intern Med; 2004 Jun; 15(3):151-156. PubMed ID: 15245716
[TBL] [Abstract][Full Text] [Related]
60. Routine follow-up by magnetic resonance imaging does not improve detection of resectable local recurrences from colorectal cancer.
Titu LV; Nicholson AA; Hartley JE; Breen DJ; Monson JR
Ann Surg; 2006 Mar; 243(3):348-52. PubMed ID: 16495699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
